These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1083 related items for PubMed ID: 26122176

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Malignant ascites enhances migratory and invasive properties of ovarian cancer cells with membrane bound IL-6R in vitro.
    Kim S, Gwak H, Kim HS, Kim B, Dhanasekaran DN, Song YS.
    Oncotarget; 2016 Dec 13; 7(50):83148-83159. PubMed ID: 27825119
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Diagnostic Model of Serum miR-193a-5p, HE4 and CA125 Improves the Diagnostic Efficacy of Epithelium Ovarian Cancer.
    Ren X, Zhang H, Cong H, Wang X, Ni H, Shen X, Ju S.
    Pathol Oncol Res; 2018 Oct 13; 24(4):739-744. PubMed ID: 29520570
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Screening and identification of biomarkers in ascites related to intrinsic chemoresistance of serous epithelial ovarian cancers.
    Huang H, Li Y, Liu J, Zheng M, Feng Y, Hu K, Huang Y, Huang Q.
    PLoS One; 2012 Oct 13; 7(12):e51256. PubMed ID: 23251472
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. A combined blood based gene expression and plasma protein abundance signature for diagnosis of epithelial ovarian cancer--a study of the OVCAD consortium.
    Pils D, Tong D, Hager G, Obermayr E, Aust S, Heinze G, Kohl M, Schuster E, Wolf A, Sehouli J, Braicu I, Vergote I, Van Gorp T, Mahner S, Concin N, Speiser P, Zeillinger R.
    BMC Cancer; 2013 Apr 03; 13():178. PubMed ID: 23551967
    [Abstract] [Full Text] [Related]

  • 32. BRCA mutational status, initial disease presentation, and clinical outcome in high-grade serous advanced ovarian cancer: a multicenter study.
    Petrillo M, Marchetti C, De Leo R, Musella A, Capoluongo E, Paris I, Benedetti Panici P, Scambia G, Fagotti A.
    Am J Obstet Gynecol; 2017 Sep 03; 217(3):334.e1-334.e9. PubMed ID: 28549976
    [Abstract] [Full Text] [Related]

  • 33. The NER-related gene GTF2H5 predicts survival in high-grade serous ovarian cancer patients.
    Gayarre J, Kamieniak MM, Cazorla-Jiménez A, Muñoz-Repeto I, Borrego S, García-Donas J, Hernando S, Robles-Díaz L, García-Bueno JM, Ramón Y Cajal T, Hernández-Agudo E, Heredia Soto V, Márquez-Rodas I, Echarri MJ, Lacambra-Calvet C, Sáez R, Cusidó M, Redondo A, Paz-Ares L, Hardisson D, Mendiola M, Palacios J, Benítez J, García MJ.
    J Gynecol Oncol; 2016 Jan 03; 27(1):e7. PubMed ID: 26463438
    [Abstract] [Full Text] [Related]

  • 34. Aurora Kinase A expression predicts platinum-resistance and adverse outcome in high-grade serous ovarian carcinoma patients.
    Mignogna C, Staropoli N, Botta C, De Marco C, Rizzuto A, Morelli M, Di Cello A, Franco R, Camastra C, Presta I, Malara N, Salvino A, Tassone P, Tagliaferri P, Barni T, Donato G, Di Vito A.
    J Ovarian Res; 2016 May 21; 9(1):31. PubMed ID: 27209210
    [Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Correlation of preoperative ROMA scores with clinical stage in epithelial ovarian cancer patients.
    Li QL, Wang CJ, Qi P, Zhang YX.
    Clin Transl Oncol; 2017 Oct 21; 19(10):1260-1267. PubMed ID: 28444641
    [Abstract] [Full Text] [Related]

  • 38. Markers of Oxidative Stress and Inflammation in Ascites and Plasma in Patients with Platinum-Sensitive, Platinum-Resistant, and Platinum-Refractory Epithelial Ovarian Cancer.
    Cantón-Romero JC, Miranda-Díaz AG, Bañuelos-Ramírez JL, Carrillo-Ibarra S, Sifuentes-Franco S, Castellanos-González JA, Rodríguez-Carrizalez AD.
    Oxid Med Cell Longev; 2017 Oct 21; 2017():2873030. PubMed ID: 28848618
    [Abstract] [Full Text] [Related]

  • 39. High levels of pretreatment CA125 are associated to improved survival in high grade serous ovarian carcinoma.
    Morales-Vásquez F, Pedernera E, Reynaga-Obregón J, López-Basave HN, Gómora MJ, Carlón E, Cárdenas S, Silva-Ayala R, Almaraz M, Méndez C.
    J Ovarian Res; 2016 Jul 07; 9(1):41. PubMed ID: 27388275
    [Abstract] [Full Text] [Related]

  • 40. Mesothelial cells interact with tumor cells for the formation of ovarian cancer multicellular spheroids in peritoneal effusions.
    Matte I, Legault CM, Garde-Granger P, Laplante C, Bessette P, Rancourt C, Piché A.
    Clin Exp Metastasis; 2016 Dec 07; 33(8):839-852. PubMed ID: 27612856
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 55.